United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.
about
Reducing the costs of chronic kidney disease while delivering quality health care: a call to action.Trans-ethnic Fine Mapping Highlights Kidney-Function Genes Linked to Salt Sensitivity.Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney diseaseFactors affecting quality of life in patients on haemodialysis: a cross-sectional study from Palestine.Rationale and study design of the prospective, longitudinal, observational cohort study "rISk strAtification in end-stage renal disease" (ISAR) studyImpact of residual urine volume decline on the survival of chronic hemodialysis patients in Kinshasa.Risk Factors of End Stage Renal Disease in Peshawar, Pakistan: Odds Ratio AnalysisHealthcare costs in chronic kidney disease and renal replacement therapy: a population-based cohort study in Sweden.Association between Clinical and Doppler Echocardiographic Parameters with Sudden Death in Hemodialysis Patients.Renal Hypoxia in CKD; Pathophysiology and Detecting Methods.A national surveillance project on chronic kidney disease management in Canadian primary care: a study protocolSafety and cardiovascular effects of mineralocorticoid receptor antagonists for patients receiving hemodialysis: a systematic review and meta-analysis.Mineral and bone disorders, morbidity and mortality in end-stage renal failure patients on chronic dialysis.Cold dialysis and its impact on renal patients' health: An evidence-based mini review.The effects of short sleep duration on proteinuria and chronic kidney disease: a systematic review and meta-analysis.The next generation of therapeutics for chronic kidney diseaseVascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho.Outcome of permanent vascular access for haemodialysis in patients with end-stage renal disease in Cameroon: results from the pilot experience of the Douala general hospital.Access to and characteristics of palliative care-related hospitalization in the management of end-stage renal disease patients on renal replacement therapy in France.(5R)-5-hydroxytriptolide ameliorates anti-glomerular basement membrane glomerulonephritis in NZW mice by regulating Fcγ receptor signaling.Obesity and risk of death or dialysis in younger and older patients on specialized pre-dialysis care.Plasma galectin-3 levels are associated with the risk of incident chronic kidney disease.The impact of hemodialysis schedules on the day of the week of hospitalization for cardiovascular and infectious diseases, over a period of 20 years.Sudden death prediction by C-reactive protein, electrocardiographic findings, and myocardial fatty acid uptake in haemodialysis patients: analysis of a multicentre prospective cohort sub-study.Serum Levels of 1,5-Anhydroglucitol and Risk of Incident End-Stage Renal Disease.Racial and Ethnic Differences in Mortality Associated with Serum Potassium in a Large Hemodialysis Cohort.Robotic kidney transplantation: one year after the beginning.Sympathetic Overactivity in Chronic Kidney Disease: Consequences and Mechanisms.Effects of listening to Holy Qur'an recitation and physical training on dialysis efficacy, functional capacity, and psychosocial outcomes in elderly patients undergoing haemodialysis.Value of bioimpedance analysis estimated "dry weight" in maintenance dialysis patients: a systematic review and meta-analysis.Aerobic exercise training rescues protein quality control disruption on white skeletal muscle induced by chronic kidney disease in rats.A 3D tri-culture system reveals that activin receptor-like kinase 5 and connective tissue growth factor drive human glomerulosclerosis.Addition of silymarin to renin-angiotensin system blockers in normotensive patients with type 2 diabetes mellitus and proteinuria: a prospective randomized trial.Global impact of nephropathies.Kidney Function Modifies the Selection of Treatment Strategies and Long-term Survival in Stable Ischemic Heart Disease: Insights from the Alberta Provincial Project for Outcomes Assessment in Coronary Heart Disease (APPROACH) Registry.Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.Computational Assessment of Blood Flow Heterogeneity in Peritoneal Dialysis Patients' Cardiac Ventricles.Progression of diabetes, ischemic heart disease, and chronic kidney disease in a three chronic conditions multistate model.Clinical and pathological characteristics of non-diabetic renal disease in type 2 diabetes patients.Advanced Diabetic Nephropathy with "Clean" Eyes: An Extreme Phenotype.
P2860
Q30234324-FD0B6E29-2CBD-4A18-B4B0-C362196D1AB8Q30276011-49211C38-AAE8-45B1-A9BC-F4FD8AADDD04Q33698768-839540A2-1157-4878-B52F-9CD4509F2F99Q36000108-3F2D1324-BA6A-4A86-8377-CC4CE972747BQ36175268-74D0AF98-5B06-4725-984F-E9092792D323Q36200137-39E43061-DC04-4E6E-86A4-2A9BC2C7E273Q37297195-7A57CF99-4762-4A0A-84E5-147378BCFF79Q37356124-868EBC8A-776F-4C4F-9812-911F858C2765Q37357070-A60D37EF-CDD0-453E-AB2F-FEE49AA16DBCQ37653803-24FCBDCA-2EDE-46E2-BEA6-0F8F286901C1Q38638683-2528F8A4-F080-4A79-96BA-7F903210FB52Q38746216-63EA435C-E8AC-4B85-B3E9-139C5D570E07Q38765338-5FFA1821-6029-46DF-B753-2D8BF5C0B68BQ38766192-A465C959-19DF-4548-BD58-F4380436D805Q38837086-E47B455B-5050-4E8E-88FD-10CF1981D35EQ38845590-9EA146BF-7FCA-4CDC-A40B-71BB0FD17E75Q39009566-60C68F65-5C39-40AD-BD35-1075D40E77A6Q39626273-12FC4EAD-A193-4C6E-B087-7088210BFEC4Q39756887-6F695032-5153-4964-9A46-A4628E022FD3Q40054103-67E835E0-D670-4551-975C-701B14B4EA28Q40057240-123DE1EC-7329-481C-A852-CC1F7FC0060BQ40060474-902C7089-A82C-4B7A-90C8-E37954149F0DQ40138047-13C5A605-9C6C-4A1C-8502-6FC155787349Q40165081-08532E91-3B11-4677-904C-BADAD1269E00Q40189389-E94EF730-9DFD-41B7-9DA6-A17CF7F66AB6Q40192340-B3887934-A2F3-47D1-9950-9DDC8B187940Q40321235-588965E0-2C0A-4AD0-8214-21D0EA37EF3FQ41573480-1BD573C5-E3A7-42B8-90A4-7A603C39FC24Q42663691-6647E271-8E33-4745-878A-45A370742D11Q47184676-3207BC8C-9927-488D-9B2C-E11F9548C2FCQ47266746-22E46C05-3CBC-48E9-AF94-C476C055B02FQ47942699-FFDD6CC6-A366-42FA-92BB-E432807B774BQ49835011-62BE4998-4DDB-40A0-9ACD-054010002E20Q49858980-2DE7A511-A634-4FD1-A29C-9BDB283DEDD0Q50140987-E82A687D-F96F-495D-BB38-BB434E4F0F95Q51758616-E9D172B6-18DD-4597-AC54-16DA54AA3485Q55235071-612C4838-E7C7-430C-B4E2-AF2A6399A3B6Q55340196-79482BE5-81C1-4B3B-864A-45217A83DA98Q55340919-93E460CB-46AF-4571-B804-F0F4B67E231FQ55413403-F9C99C4E-4B15-45B5-AB1D-B3528B63D515
P2860
United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
United States Renal Data Syste ...... e and end-stage renal disease.
@ast
United States Renal Data Syste ...... e and end-stage renal disease.
@en
type
label
United States Renal Data Syste ...... e and end-stage renal disease.
@ast
United States Renal Data Syste ...... e and end-stage renal disease.
@en
prefLabel
United States Renal Data Syste ...... e and end-stage renal disease.
@ast
United States Renal Data Syste ...... e and end-stage renal disease.
@en
P2093
P2860
P356
P1476
United States Renal Data Syste ...... e and end-stage renal disease.
@en
P2093
Allan J Collins
David T Gilbertson
Robert N Foley
Shu-Cheng Chen
P2860
P2888
P356
10.1038/KISUP.2015.2
P577
2015-06-01T00:00:00Z
P5875
P6179
1053351156